• Newsroom_Corebio_square

    CU Innovations and Core Bio Announce Strategic PartnershipOpens in a new window

    Aug 16, 2023
    DENVER and SAN FRANCISCO, Aug. 16, 2023 /PRNewswire/ -- Core Biotherapeutics, a platform biotech company focused on creating the next generation of drugs to transform the lives of patients with cancer and other life-threatening diseases, has entered into a collaboration with the University of Colorado Anschutz Medical Campus (CU Anschutz) to expand the benefits of their therapeutic approach to Acute Myeloid Leukemia (AML) patients. This partnership was facilitated by CU Innovations, the CU Anschutz department tasked with bringing together industry partners, entrepreneurs, investors, and CU Anschutz researchers to translate technology to improve outcomes for patients worldwide.
    Opens in a new window Full story
  • Laxxon Medical and CU Anschutz

    Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic PartnershipOpens in a new window

    Jul 17, 2023
    DENVER, CO / ACCESSWIRE / July 17, 2023 / Laxxon Medical, a leading 3D screen printing pharma-technology company, announced today their strategic partnership with CU Innovations at the University of Colorado Anschutz Medical Campus (CU Anschutz). The partnership will create an opportunity for researchers at CU Anschutz to develop novel drug therapies using Laxxon's 3D screen printing technology, SPID®-Technology (Screen Printing Innovational Drug Technology).
    Opens in a new window Full story
  • SPARK|REACH Cohort 6

    SPARK | REACH Program Offers Bridge to Patient Bedside for Promising Treatments

    Jun 19, 2023
    The SPARK | REACH Program is the go-to program on campus for anyone who has promising proof-of-concept data in the lab. SPARK helps develop technologies that address unmet medical needs and will open for new applications on June 19.
    Full story
  • Showing 1 - 3 of 24 results

Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection

 Royal Philips , a global leader in health technology, and BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.


UCHealth deploys BioIntelliSense BioButton™ Vaccine Monitoring Solution to health care workers receiving COVID-19 vaccine

As UCHealth begins administering the Pfizer COVID-19 vaccine to health care workers today at University of Colorado Hospital on the University of Colorado Anschutz Medical Campus, some recipients will be wearing the BioIntelliSense BioButton medical device as a foundational step in developing a scalable post-vaccine monitoring program that could be deployed more broadly in high-risk patient populations.

pipet and vial

Four CU Researchers Awarded AIA Funding

A Colorado company with revolutionary technology to create telepresence robotics, designed  to expedite adoption of robotic arms in advanced industrial and commercial applications was among 37 Colorado start-ups approved for funding as part of the Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program. A total of $7,657,811 was approved during the first grant cycle of 2021 for Proof-of-Concept and Early Stage Capital and Retention Grants that support Colorado’s advanced industries.

scientists around lab bench

BridgeBio and CU Anschutz Announce Collaboration

BridgeBio and CU Anschutz announce a collaboration to advance novel research on genetically driven diseases into therapeutic applications for patients.

UCHealth hospital in Aurora, CO

New technology allows cancer patients to watch movies during radiation

No matter the age, radiation treatment can be tough on any cancer patient. That’s why UCHealth helped develop a special piece of technology to help reduce anxiety and stress associated with it.


CU Anschutz Awarded Grant to Advance Academic Discoveries

The University of Colorado Anschutz Medical Campus has been awarded $4 million over the next four years from the National Institutes of Health (NIH) Research Evaluation and Commercialization Hubs (REACH) grant.

News Signup

Be first to know about innovations 

What types of news are you interested in?